{"url_path":"/sec/cik-0001098009/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1098009/0001185185-26-002331-index.html","accession_number":"0001185185-26-002331","cik":"0001098009","ticker":null,"issuer_name":"America Great Health","edgar_url":"https://www.sec.gov/Archives/edgar/data/1098009/0001185185-26-002331-index.html","primary_entity_key":"0001098009","primary_entity_name":"America Great Health"},"word_count":445,"has_tables":true,"body_markdown":"**UNITED\nSTATES**\n\n**SECURITIES AND\nEXCHANGE COMMISSION**\n\n**Washington, D.C.\n20549**\n\n \n\n \n\n \n\n**FORM 10-Q**\n\n \n\n \n\n \n\n☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the quarterly\nperiod ended September 30, 2025\n\n \n\n☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the transition\nperiod from ______ to ______\n\n \n\n**Commission File No. 000-27873**\n\n \n\n**America Great Health**\n\n(Exact name of registrant\nas specified in its charter)\n\n  \n\n**Wyoming**   **98-0178621**\n\n(State or other jurisdiction of   (I.R.S. Employer\n\nincorporation or organization)   Identification No.)\n\n \n\n**1609 W Valley Blvd Unit 338A**    \n\n**Alhambra, CA**   **91803**\n\n(Address of principal executive offices)   (Zip Code)\n\n \n\n**(888)\n988-1333**\n\n(Registrant’s telephone number, including area code)  \n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each class   Trading Symbol(s)   Name of each exchange on which registered\n\nN/A   N/A   N/A\n\n \n\nIndicate by check mark whether the registrant\n(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12\nmonths (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements\nfor the past 90 days. Yes ☐ No ☒\n\n \n\nIndicate by check mark whether the registrant\nhas submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405\nof this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes\n☐ No ☒\n\n \n\nIndicate by check mark whether the registrant\nis a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.\nSee the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”\nand “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐\n\nNon-accelerated filer ☒ Smaller reporting company ☒\n\n  Emerging growth company ☐\n\n  \n\nIf an emerging growth company, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant\nto Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as\ndefined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\nIndicate the number of shares outstanding of each of the registrant’s\nclasses of common stock, as of the latest practicable date. The number of shares outstanding of the registrant’s common stock as\nof June 3, 2026 was 21,204,811,608. This number includes 52,150,000 shares of treasury shares.\n\n \n\n \n\n  \n\n \n\n \n\n \n\n**AMERICA GREAT HEALTH AND SUBSIDIARIES**\n\n \n\n**TABLE OF CONTENTS**\n\n \n\n[**PART I**– **FINANCIAL INFORMATION**](#via_001)\n**1**"}